SANOFI VACCINES US INC.: $965M Department of Health and Human Services Contract Vehicle
Summary
This $965M CDC contract for the Vaccines for Children program is a routine annual renewal. The recipient, Sanofi Vaccines US Inc., is a private entity, so no direct public company exposure exists. The contract supports public health infrastructure but does not generate actionable market signals for retail investors.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.No public company exposure – recipient is private, not a recognized public subsidiary.
- 2.Routine CDC contract for children's vaccines – not a new initiative or policy shift.
- 3.No legislation directly links to this award; unrelated bills have minimal sector impact.
Market Implications
This contract has no direct implications for publicly traded stocks. Investors seeking exposure to vaccine manufacturing should monitor other public companies (e.g., Merck, Pfizer) that participate in federal vaccine programs but this specific award is not attributable to them. The healthcare sector overall sees steady demand from government programs but this contract size relative to the sector is negligible.
Full Analysis
The Department of Health and Human Services, through the CDC, awarded a $965M indefinite delivery/indefinite quantity contract to Sanofi Vaccines US Inc. for the Vaccines for Children (VFC) program covering FY25 (April 2025 to March 2026). The VFC program provides free vaccines to eligible children and is a longstanding federal initiative. The recipient is a private entity (Sanofi Vaccines US Inc.), and per regulatory guidelines, this contract cannot be mapped to any publicly traded company, including its parent company Sanofi (SNY), because the award does not specify a clear public parent-subsidiary relationship that can be reliably attributed. There are no related bill signals that directly authorize or fund this specific contract; the listed bills address other policy areas. Consequently, no publicly traded companies, supply chain beneficiaries, or subcontractors can be identified with confidence. The contract is a routine operational renewal with negligible market-moving potential for public equities.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
DEPARTMENT OF HUMAN SERVICES HAWAII: $2.2B Department of Health and Human Services Grant
KANSAS DEPARTMENT OF HEALTH & ENVIRONMENT: $4.6B Department of Health and Human Services Grant
NEW MEXICO HEALTH CARE AUTHORITY: $9.4B Department of Health and Human Services Grant
HEALTH SERVICES KENTUCKY CABINET FOR: $18.2B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.1B Department of Health and Human Services Federal Award
ARIZONA HEALTH CARE COST CONTAINMENT SYSTEM: $19.6B Department of Health and Human Services Grant
MULTIPLE RECIPIENTS: $4.6B Department of Health and Human Services Federal Award
HEALTH CARE SERVICES, CALIFORNIA DEPARTMENT OF: $6.2B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Contract Details
Recipient
SANOFI VACCINES US INC.
Award Amount
$964,721,458
Awarding Agency
Department of Health and Human Services
Sub-Agency
Centers for Disease Control and Prevention
Contract Type
INDEFINITE DELIVERY / INDEFINITE QUANTITY
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →